Korde, N., Carlsten, M., Lee, M.-J., Minter, A., Tan, E., Kwok, M., Manasanch, E., Bhutani, M., Tageja, N., Roschewski, M., Zingone, A., Costello, R., Mulquin, M., Zuchlinski, D., Maric, I., Calvo, K. R., Braylan, R., Tembhare, P., Yuan, C., Stetler-Stevenson, M., Trepel, J., Childs, R. and Landgren, O. (2014) “A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma”, Haematologica. Pavia, Italy, 99(6), pp. e81-e83. doi: 10.3324/haematol.2013.103085.